Cable Viewer

Currently released so far... 12453 / 251,287

### Browse latest releases

2010/11 2010/12 2011/01 2011/02 2011/03 2011/04 2011/05
2010/11/28 2010/11/29 2010/11/30
2010/12/01 2010/12/02 2010/12/03 2010/12/04 2010/12/05 2010/12/06 2010/12/07 2010/12/08 2010/12/09 2010/12/10 2010/12/11 2010/12/12 2010/12/13 2010/12/14 2010/12/15 2010/12/16 2010/12/17 2010/12/18 2010/12/19 2010/12/20 2010/12/21 2010/12/22 2010/12/23 2010/12/24 2010/12/25 2010/12/26 2010/12/27 2010/12/28 2010/12/29 2010/12/30
2011/01/01 2011/01/02 2011/01/04 2011/01/05 2011/01/07 2011/01/09 2011/01/10 2011/01/11 2011/01/12 2011/01/13 2011/01/14 2011/01/15 2011/01/16 2011/01/17 2011/01/18 2011/01/19 2011/01/20 2011/01/21 2011/01/22 2011/01/23 2011/01/24 2011/01/25 2011/01/26 2011/01/27 2011/01/28 2011/01/29 2011/01/30 2011/01/31
2011/02/01 2011/02/02 2011/02/03 2011/02/04 2011/02/05 2011/02/06 2011/02/07 2011/02/08 2011/02/09 2011/02/10 2011/02/11 2011/02/12 2011/02/13 2011/02/14 2011/02/15 2011/02/16 2011/02/17 2011/02/18 2011/02/19 2011/02/20 2011/02/21 2011/02/22 2011/02/23 2011/02/24 2011/02/25 2011/02/26 2011/02/27 2011/02/28
2011/03/01 2011/03/02 2011/03/03 2011/03/04 2011/03/05 2011/03/06 2011/03/07 2011/03/08 2011/03/09 2011/03/10 2011/03/11 2011/03/13 2011/03/14 2011/03/15 2011/03/16 2011/03/17 2011/03/18 2011/03/19 2011/03/20 2011/03/21 2011/03/22 2011/03/23 2011/03/24 2011/03/25 2011/03/26 2011/03/27 2011/03/28 2011/03/29 2011/03/30 2011/03/31
2011/04/01 2011/04/02 2011/04/03 2011/04/04 2011/04/05 2011/04/06 2011/04/07 2011/04/08 2011/04/09 2011/04/10 2011/04/11 2011/04/12 2011/04/13 2011/04/14 2011/04/15 2011/04/16 2011/04/17 2011/04/18 2011/04/19 2011/04/20 2011/04/21 2011/04/22 2011/04/23 2011/04/24 2011/04/25 2011/04/26 2011/04/27 2011/04/28 2011/04/29 2011/04/30
2011/05/01 2011/05/02 2011/05/03 2011/05/04 2011/05/05

### Browse by creation date

66 72 73 75 79 85 86 87 88 89 90 91 92 93 96 97 00 01 02 03 04 05 06 07 08 09 10
1966/12
1972/02 1972/08
1973/04
1975/03
1979/08
1985/03 1985/06
1986/05
1987/06
1988/01
1989/12
1990/01 1990/07 1990/08 1990/10
1991/05
1992/01 1992/06 1992/12
1993/10
1996/11
1997/12
2000/05 2000/06 2000/09 2000/11
2001/02 2001/03 2001/06 2001/07 2001/09 2001/10 2001/11
2002/01 2002/02 2002/03 2002/04 2002/07 2002/08 2002/09 2002/11
2003/01 2003/02 2003/03 2003/04 2003/05 2003/06 2003/07 2003/08 2003/09 2003/10 2003/11 2003/12
2004/01 2004/02 2004/03 2004/04 2004/05 2004/06 2004/07 2004/08 2004/09 2004/10 2004/11 2004/12
2005/01 2005/02 2005/03 2005/04 2005/05 2005/06 2005/07 2005/08 2005/09 2005/10 2005/11 2005/12
2006/01 2006/02 2006/03 2006/04 2006/05 2006/06 2006/07 2006/08 2006/09 2006/10 2006/11 2006/12
2007/01 2007/02 2007/03 2007/04 2007/05 2007/06 2007/07 2007/08 2007/09 2007/10 2007/11 2007/12
2008/01 2008/02 2008/03 2008/04 2008/05 2008/06 2008/07 2008/08 2008/09 2008/10 2008/11 2008/12
2009/01 2009/02 2009/03 2009/04 2009/05 2009/06 2009/07 2009/08 2009/09 2009/10 2009/11 2009/12
2010/01 2010/02

### Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z
Embassy Athens Embassy Asuncion Embassy Astana Embassy Asmara Embassy Ashgabat Embassy Apia Embassy Ankara Embassy Amman Embassy Algiers Embassy Addis Ababa Embassy Accra Embassy Abuja Embassy Abu Dhabi Embassy Abidjan Consulate Auckland Consulate Amsterdam Consulate Adana American Institute Taiwan, Taipei
Embassy Bujumbura Embassy Buenos Aires Embassy Budapest Embassy Bucharest Embassy Brussels Embassy Bridgetown Embassy Bratislava Embassy Brasilia Embassy Bogota Embassy Bishkek Embassy Bern Embassy Berlin Embassy Belmopan Embassy Belgrade Embassy Beirut Embassy Beijing Embassy Banjul Embassy Bangkok Embassy Bandar Seri Begawan Embassy Bamako Embassy Baku Embassy Baghdad Consulate Barcelona
Embassy Copenhagen Embassy Conakry Embassy Colombo Embassy Chisinau Embassy Caracas Embassy Canberra Embassy Cairo Consulate Curacao Consulate Ciudad Juarez Consulate Chennai Consulate Casablanca Consulate Cape Town Consulate Calgary
Embassy Dushanbe Embassy Dublin Embassy Doha Embassy Djibouti Embassy Dili Embassy Dhaka Embassy Dar Es Salaam Embassy Damascus Embassy Dakar Consulate Dubai
Embassy Freetown
Embassy Guatemala Embassy Gaborone Consulate Guayaquil Consulate Guadalajara
Embassy Helsinki Embassy Harare Embassy Hanoi Consulate Ho Chi Minh City Consulate Hermosillo Consulate Hamilton Consulate Hamburg Consulate Halifax
Iran RPO Dubai Embassy Islamabad Consulate Istanbul
Embassy Jakarta Consulate Jerusalem Consulate Jeddah
Embassy Kyiv Embassy Kuwait Embassy Kuala Lumpur Embassy Kinshasa Embassy Kingston Embassy Kigali Embassy Khartoum Embassy Kathmandu Embassy Kampala Embassy Kabul Consulate Kolkata
Embassy Luxembourg Embassy Luanda Embassy London Embassy Ljubljana Embassy Lisbon Embassy Lima Embassy Lilongwe Embassy La Paz Consulate Lahore Consulate Lagos
Mission USOSCE Mission USNATO Mission UNESCO Embassy Muscat Embassy Moscow Embassy Montevideo Embassy Monrovia Embassy Minsk Embassy Mexico Embassy Mbabane Embassy Maputo Embassy Manila Embassy Manama Embassy Managua Embassy Malabo Embassy Madrid Consulate Munich Consulate Mumbai Consulate Montreal Consulate Monterrey Consulate Milan Consulate Melbourne
Embassy Nicosia Embassy Niamey Embassy New Delhi Embassy Ndjamena Embassy Nassau Embassy Nairobi Consulate Naples Consulate Naha
Embassy Ouagadougou Embassy Ottawa Embassy Oslo
Embassy Pristina Embassy Pretoria Embassy Prague Embassy Port Of Spain Embassy Port Louis Embassy Port Au Prince Embassy Phnom Penh Embassy Paris Embassy Paramaribo Embassy Panama Consulate Peshawar
Embassy Quito Consulate Quebec
REO Basrah Embassy Rome Embassy Riyadh Embassy Riga Embassy Reykjavik Embassy Rangoon Embassy Rabat Consulate Rio De Janeiro Consulate Recife
Secretary of State Embassy Suva Embassy Stockholm Embassy Sofia Embassy Skopje Embassy Singapore Embassy Seoul Embassy Sarajevo Embassy Santo Domingo Embassy Santiago Embassy Sanaa Embassy San Salvador Embassy San Jose Consulate Strasbourg Consulate St Petersburg Consulate Shenyang Consulate Shanghai Consulate Sao Paulo
Embassy Tunis Embassy Tripoli Embassy Tokyo Embassy The Hague Embassy Tel Aviv Embassy Tehran Embassy Tegucigalpa Embassy Tbilisi Embassy Tashkent Embassy Tallinn Consulate Toronto Consulate Tijuana
USUN New York USEU Brussels US Office Almaty US Mission Geneva US Interests Section Havana US Delegation, Secretary UNVIE Embassy Ulaanbaatar
Embassy Vilnius Embassy Vienna Embassy Vatican Embassy Valletta Consulate Vladivostok Consulate Vancouver
Embassy Windhoek Embassy Wellington Embassy Warsaw
Embassy Yerevan Embassy Yaounde
Embassy Zagreb

### Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ASEC AORC AMGT APER AU AF AS ACBAQ AFGHANISTAN AFIN AR AE AJ ADANA AEMR AG ATRN ADPM APECO AGAO AMED AX AM AL ADCO AA AECL AADP ABUD AMEX ACAO ANET AODE ASCH AY APEC AID AORG ASEAN AFSI AFSN AINF AGR AROC AO AMBASSADOR AFFAIRS ASIG ABLD ASUP AND ARM ARF AQ ATFN AC ACOA AORL ADM AUC AGMT ACABQ ASEX AFU ALOW AZ APCS AVERY ASECKFRDCVISKIRFPHUMSMIGEG AER AN AIT AMG AGRICULTURE AMCHAMS ACS
BR BA BD BL BO BF BU BILAT BEXP BRUSSELS BK BN BM BT BY BX BTIO BIDEN BG BE BP BBSR BC BTIU BWC BB BH BMGT
CH CY CA CU CS CO CVIS CPAS CMGT CE COUNTER CASC COUNTRY CJAN COUNTERTERRORISM CG CI CD CIDA CJUS CDG CBSA CEUDA CR CM CLMT CAC CBW CODEL COPUOS CWC CIC CW CBE CHR CFED CT CONS CIA CTM CDC CVR CF CLINTON CITEL CLEARANCE COE CN CACS CAN CONDOLEEZZA CB CSW CITT CARSON CNARC CACM CDB CARICOM COM CROS CAPC CTR CV CKGR CBC CL CICTE CIS
DR DHS DA DJ DEA DPRK DEPT DOMESTIC DEAX DOE DS DAO DCM DO DE DK DEFENSE DTRA DISENGAGEMENT DOD
ECON EFIN ELAB ETRD EIND EC EINV EAGR ENRG ETTC EAID EPET ELTN EWWT EAIR EFIS EMIN EG EU ER EUN EPA ENVI EXTERNAL ECPS ENGR ETRC ECIN EN EI ELN ET EINT ETRDEINVTINTCS ES ETRDEINVECINPGOVCS EZ ETRO EDU ETRN EFTA EAIG EK EUREM EURN ECONCS ECONOMICS ENVR ELECTIONS EAP ENIV ECONOMY ESA EINN ECONOMIC EIAR EXBS ECA ECUN EINDETRD EUR EREL EUC ESENV ECONEFIN ECIP ENERG ENNP EFINECONCS EFIM ENGY EAIDS EINVEFIN EINVETC EUMEM ETRA ETC ERNG ETRDECONWTOCS EUNCH ECINECONCS EINVECONSENVCSJA EXIM ERD EEPET
FR FREEDOM FTA FJ FARC FI FTAA FAC FBI FOREIGN FOI FDA FM FAO FAS FINR FOR FINANCE FMLN FO FISO
GM GV GOI GOV GL GAERC GH GT GG GA GY GR GF GCC GE GZ GTIP GERARD GLOBAL GANGS GAZA GTMO
HA HR HUMAN HO HK HU HILLARY HUMOR HI HSTC HURI HYMPSK HEBRON
IR IS IZ IAEA IO IAHRC ID IC IT IRAQI IWC IN IL ISLAMISTS IV ICAO INDO ITPHUM ITPGOV ITALIAN IPR ICRC INTERPOL IQ IBET IMO INR ITRA INTERNAL ICJ ICTY IRS ILO INRA INRO ISRAELI IEA INRB ITALY ITU IBRD IIP ILC INTELSAT IZPREL IMF INMARSAT IRAJ IDA ICTR IA IGAD IF IDP ITF ISRAEL IEFIN IRC IACI
JA JUS JO JP JOSEPH JM JAMES JOHNNIE JOHN
KN KCRM KOMC KNNPMNUC KIPR KPAL KWBG KSCA KFRD KNNP KUNR KTIP KWMN KSTC KFLU KOLY KISL KPAO KMDR KJUS KSTH KDEM KCOR KIRF KAWC KU KTFN KWAC KNPP KERG KSEO KACT KHLS KZ KGHG KTIA KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KCRCM KE KPKO KCIP KDRG KVPR KV KIDE KICC KPRP KBIO KSUM KGIT KCFE KG KBTS KFLO KMPI KS KGIC KPAI KHSA KTLA KSEP KTEX KFSC KOCI KHDP KPLS KTDB KHIV KCSY KSAC KTRD KID KMRS KOM KSAF KRVC KR KMOC KNAR KIRC KBCT KSPR KFIN KBTR KJUST KNEI KAWK KGCC KMCA KREL KMFO KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KFTFN KVRP KCOM KO KLIG KAID KVIR KNSD KHUM KSEC KRAD KPRV KCMR KPWR KCHG KIFR KCFC KICA KPIN KSCI KESS KDEV KTBT KCRS KCGC KOMS KRIM KTER KREC KPOA KWWMN KRGY KPAK KWNM KMIG KDDG KRFD KWMM KWMNCS KX KRCM KPAONZ KNUC KDEMAF KNUP
LY LE LO LG LH LI LTTE LAB LOG LA LT LU LABOR
MARR MOPS MASS MCAP MTCRE MNUC MIL MX MEDIA MO MPOS MU ML MA MP MY MERCOSUR MG MD MW MK MAS MEETINGS MR MT MI MOPPS MASC MTS MLS MILI MAR MTRE MEPN MAPP MTCR MEPI MQADHAFI MAPS MARAD MASSMNUC MEPP MCC MZ MILITARY MDC MRCRE MC MV MIK MUCN
NATO NL NZ NPT NI NAFTA NU NDP NIPP NP NPA NG NRR NO NSC NEW NE NH NR NA NS NSF NZUS NATIONAL NSG NC NT NAR NK NGO NV NSFO NSSP NASA NW NPG NORAD NATOPREL
OTRA OAS OPRC OIIP OVIP OREP OPDC OEXC OSCE OFFICIALS OMIG ODIP OFDP OECD OPIC OBSP OPCW OFDA OTR OSAC OSCI ON OCII OES OVP OIC OPAD OIE OHUM OCS
PREL PGOV PK PHUM PINS PARM PA PTER PINR PREF PHSA PBTS PBIO PO POL PE PARMS PM PROG PL PAK POLITICS PORG PTBS PNAT PUNE POLICY PDOV PCI PROP PGOVSMIGKCRMKWMNPHUMCVISKFRDCA PBT PP PS PAO PG PY PTERE PGOF PALESTINIAN PKFK PSOE PEPR PPA PINT PMAR PRELP PSEPC PREFA PGOVE PINF PHUMPGOV PNG PMIL PGOC PFOR PCUL PLN PSA PGIV POLINT PAS POGOV PHUMPREL PHUMBA PEL PGGV PNR PHALANAGE PARTY PGOVLO PRAM PHUS PDEM PECON PF POV PROV PRL PREO PAHO PHUH PSI PINL PU PRGOV PAIGH POLITICAL PARTIES POSTS
QA
RS RU REACTION REPORT REGION RIGHTS RO RW RCMP RF RM RFE RSP RP RICE ROBERT ROOD RELATIONS RIGHTSPOLMIL RUPREL RSO
SU SNAR SO SOCI SW SENV SMIG SCUL SP SZ SENVKGHG SR SY SA SYRIA SF SI SC SWE SARS STEINBERG SN SG SIPRS ST SEVN SL SPCE SNARIZ SSA SNARCS SYR SK SPCVIS SHUM SIPDIS SHI SH SOFA SEN SNARN SAARC SAN SANC SCRS
TRGY TBIO TU TF TERRORISM TI TSPL TPHY TH TIP TSPA TC TO TW TX TZ TNGD TT TL TV TFIN TS TRSY TINT TN TURKEY TBID TD TK TR THPY TP TAGS
UNGA UN UK US UNC UNSC USUN UG UP UY USEU UNESCO USPS USTR UZ UNHRC UNO UNMIK UNAUS UNHCR UNCHR USAID UNVIE UAE USOAS UNFICYP UV UNEP UNODC UNCHS UNIDROIT UNDESCO UNDC UNCHC UNDP UNCND USNC UNPUOS UNICEF UNCSD UE
VT VE VTPREL VM VZ VI VTIZ VAT VN VC VTEG
WS WTO WTRO WTRQ WI WZ WHO WFP WBG WITH WWARD WHA WB WIPO WA WMO WMD WHTI WEU
XA XF XM XL XW XV XR XB XU XY XH XG XE XK XX XD XI XS XT XTAG XQ XZ XC
YE YM YI YMCS
ZI ZO ZU ZEALAND ZK ZR ZF ZP ZN ZA ZB ZOELLICK ZL ZJ ZANU

### Browse by classification

CONFIDENTIAL CONFIDENTIAL//NOFORN SECRET SECRET//NOFORN UNCLASSIFIED UNCLASSIFIED//FOR OFFICIAL USE ONLY

### Community resources

Follow us on Twitter Check our Reddit Twitter this Digg this page Contact us on IRC

courage is contagious

### Viewing cable 08HELSINKI311, FINNISH GOVERNMENT APPROVES PHARMACEUTICAL

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs
Understanding cables
Every cable message consists of three parts:

- The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
- The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
- The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.

To understand the justification used for the classification of each cable, please use this WikiSource article as reference.
Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #08HELSINKI311.

Reference ID | Created | Released | Classification | Origin
--- | --- | --- | --- | ---
08HELSINKI311 | 2008-07-09 09:09 | 2011-04-24 00:12 | UNCLASSIFIED | Embassy Helsinki

`

    VZCZCXYZ0002
    RR RUEHWEB

    DE RUEHHE #0311/01 1910935
    ZNR UUUUU ZZH
    R 090935Z JUL 08
    FM AMEMBASSY HELSINKI
    TO RUEHC/SECSTATE WASHDC 4415
    RUCPDOC/DEPT OF COMMERCE WASHDC
    INFO RUCNMEU/EU INTEREST COLLECTIVE
    RUEHNY/AMEMBASSY OSLO 4744

` `

    UNCLAS HELSINKI 000311

    SIPDIS

    E.O. 12958: N/A
    TAGS: ETRD FI PREL
    SUBJECT: FINNISH GOVERNMENT APPROVES PHARMACEUTICAL

    REFERENCE PRICING SYSTEM

    ¶1. Summary:  In a disappointing move and despite Embassy and
    industry efforts, the Finnish cabinet voted unanimously June
    25 to approve a reference pricing scheme for pharmaceuticals,
    a provision of which undermines the value of patent
    protection for medicines created and manufactured by U.S. and
    other pharmaceutical companies. Parliament is expected to
    approve the proposal at the end of the summer.  Despite the
    fact that the Ministry of Economy and Employment, the
    Ministry of Foreign Affairs and the Chancellor of Justice
    initially opposed the proposal and Prime Minister Vanhanen
    was equivocal, in the end all acquiesced and supported the
    Minister of Social Affairs and Health and the short-term
    attraction of an estimated 50 million euros annually in
    savings.  Embassy will engage key parliamentary figures in
    the next month to urge that the government develop a revised
    proposal that achieves their stated objective of containing
    health care costs but that will maintain the level of
    intellectual property protection that pharmaceutical
    companies have previously enjoyed in Finland and continue to
    enjoy elsewhere in the European Union.  If the proposal
    passes as written, post will consult with local U.S. industry
    and Washington to determine if a Special 301 listing is
    appropriate in the 2009 cycle.  End Summary.

    ----------
    Background
    ----------

    ¶2.  Product patents have been granted in Finland only since
    ¶1995.  As such, nearly all products on the Finnish market are
    still protected only by analoguous process patents.  Prior to
    2006, when Finland enacted the fix it is now proposing to
    withdraw, the level of protection for innovative medicines in
    Finland was among the lowest in the EU.  At that time,
    industry faced three major hurdles that taken together formed
    a perfect storm:  weak patent protection, liberal market
    authorization and mandatory generic substitution.

    --------------------------------------------- -------
    Finland Does the Right Thing But Then Changes Course
    --------------------------------------------- -------

    ¶3.  After much Industry and Embassy lobbying, in 2006, the
    Finnish government established criteria in Section 57(c) of
    its Medicines Act that excluded pharmaceutical products from
    generic reimbursement if they were protected by an analogus
    process patent in Finland and enjoyed valid patent protection
    in at least five other countries in the European Union.
    57(c) was the result of long negotiations and was seen by
    industry as a fair and equitable solution.  Indeed, it was
    used as an example for other countries, notably Norway, of
    the ideal legislative remedy.  Trouble started in the summer
    of 2007 when the Finnish Pharmaceutical Pricing Board (PPB)
    began cancelling the reimbursement status of some innovative
    drugs, claiming the PPB was bound only by the Health
    Insurance Act, not the the Medicines Act that contained the
    exclusion criteria. At first, Industry and Econoff believed
    this was an isolated action by an overzealous PPB chief,
    especially because when we raised it with the newly-installed
    Health Minister, she freely admitted she did not know what we
    were talking about.  Clearly she eventually got up to speed,
    because before long her ministry was overtly supporting the
    complete withdrawal of the 57(c) arrangement instead of
    supporting similar exclusion criteria for the Health
    Insurance Act as industry was proposing.

    ------------------------
    USG and Industry Efforts
    ------------------------

    ¶4. Beginning late last year, Econoff and Commercial Officer
    began working closely with the U.S. pharmaceutical company
    representatives here in Finland as well as with the local
    trade association Pharma Industry Finland (PIF) and its
    director, former Finance Minister Suvi-Anne Siimes to devise
    a strategy to head off the cancellation of 57(c).  Since
    January 2008 the Embassy has raised this at the highest level
    of Finnish government, including with the Prime Minister but
    also with virtually every other minister in the entire
    government.  Our strategy, carefully coordinated with
    industry and Washington, has focused on underscoring that
    Finland's knowledge-based economy has attracted much r&d
    investment, including health-related project funds from the
    USG.  A small IPR deficiency would undermine Finland's
    deserved reputation for innovation, a blow that was surely
    not worth the short-term gains from savings.  Industry
    reinforced this message during the visit of Alex Azar, Eli
    Lilly's Senior VP for Corporate Affairs (and a former Deputy
    Secretary of HHS) and through intensive lobbying by PIF and
    Siimes.  Siimes has also reached out to the German, French

    and Swiss Embassies whose companies also stand to suffer
    under the new arrangement.  USTR Ambassador Schwab and
    Secretary Gutierrez have written their Finnish counterparts
    on this issue and it has been raised with the Finnish Embassy
    in Washington and during the visits of high-level Finnish
    government officials.

    ----------
    Next Steps
    ----------

    ¶5.  With the cabinet's approval of the reference pricing
    scheme and the subsequent removal of the protection
    innovative products enjoyed under Section 57(c), there are
    few steps left.  Nonetheless, Embassy has a small window
    until the end of the summer when parliament will reconvene
    and consider the proposal.  Given that the MPs' party
    representatives in the cabinet have already approved the
    proposal, however, chances for success are slim.  However, we
    remain committed to raising this with parliamentary leaders
    in an attempt to encourage the development of a revised
    proposal.  If that fails, we will examine whether this
    unfortunate set of events merits Finland's inclusion on the
    Special 301 list.

    BUTLER

`